Researchers characterized C5aR2, a complement receptor described as exhibiting atypical signaling behavior that differs from classical models of complement receptor activation. The work, presented as defining the molecular underpinnings of C5aR2 signaling and agonist behavior, highlights how the receptor works alongside C5aR1 to influence inflammatory effects mediated by complement anaphylatoxin C5a.